未登录 Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study Filgotinib在类风湿关节炎患者中的安全性与有效性：DARWIN 3长期扩展研究的最终结果 Westhovens, Rene; Winthrop, Kevin L.; Kavanaugh, Arthur; Greenwald, Maria; Cseuz, Regina; de Vries, Dick; Modgill, Vikas; Le, Ly Huong; Genovese, Mark C.; Emery, Paul; Verschueren, Patrick; Alten, Rieke 分享 收藏
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients Tofacitinib与肿瘤坏死因子抑制剂在心血管风险富集的类风湿关节炎患者中的静脉血栓栓塞风险 Charles-Schoeman, Christina; Fleischmann, Roy; Mysler, Eduardo; Greenwald, Maria; Ytterberg, Steven R.; Koch, Gary G.; Bhatt, Deepak L.; Wang, Cunshan; Mikuls, Ted R.; Chen, All-shine; Connell, Carol A.; Woolcott, John C.; Menon, Sujatha; Chen, Yan; Lee, Kristen; Szekanecz, Zoltan 分享 收藏
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis Tuttle, Jay; Drescher, Edit; Simon-Campos, Jesus Abraham; Emery, Paul; Greenwald, Maria; Kivitz, Alan; Rha, Hyungmin; Yachi, Pia; Kiley, Christina; Nirula, Ajay 分享 收藏
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs Kavanaugh, Arthur; Westhovens, Rene R.; Winthrop, Kevin L.; Lee, Susan J.; Tan, YingMeei; An, Di; Ye, Lei; Sundy, John S.; Besuyen, Robin; Meuleners, Luc; Stanislavchuk, Mykola; Spindler, Alberto J.; Greenwald, Maria; Alten, Rieke; Genovese, Mark C. 分享 收藏
LONG TERM SAFETY AND EFFICACY OF FILGOTINIB IN A PHASE 2B OPEN LABEL EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS UP TO 144 WEEKS Alten, R.; Westhovens, R.; Kavanaugh, A.; Genovese, M.; Winthrop, K.; Greenwald, M.; Ponce, L.; Enriquez, F.; Stanislavchuk, M.; Mazur, M.; Spindler, A.; Cseuz, R.; Nikulenkova, N.; Glowacka-Kulesz, M.; Szombati, I.; Dudek, A.; Meuleners, L.; Tasset, C.; Harrison, P.; Van der Aa, A. 分享 收藏
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1) Filgotinib (GLPG0634/GS-6034) 是一种口服JAK1选择性抑制剂，与甲氨蝶呤 (MTX) 联合治疗对活动性类风湿关节炎和对MTX反应不足的患者有效: 一项随机剂量研究的结果 (达尔文1) Westhovens, R.; Taylor, P. C.; Alten, R.; Pavlova, D.; Enriquez-Sosa, F.; Mazur, M.; Greenwald, M.; Van der Aa, A.; Vanhoutte, F.; Tasset, C.; Harrison, P. 分享 收藏
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis Genovese, Mark C.; Greenwald, Maria; Codding, Christine; Zubrzycka-Sienkiewicz, Anna; Kivitz, Alan J.; Wang, Annie; Shay, Kathyjo; Wang, Xuegong; Garg, Jay P.; Cardiel, Mario H. 分享 收藏
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study Dougados, Maxime; van der Heijde, Desiree; Chen, Ying-Chou; Greenwald, Maria; Drescher, Edit; Liu, Jiajun; Beattie, Scott; Witt, Sarah; de la Torre, Inmaculada; Gaich, Carol; Rooney, Terence; Schlichting, Douglas; de Bono, Stephanie; Emery, Paul 分享 收藏
Safety and Efficacy of SBI-087, a Subcutaneous Agent for B Cell Depletion, in Patients with Active Rheumatoid Arthritis: Results from a Phase II Randomized, Double-blind, Placebo-controlled Study Damjanov, Nemanja; Tlustochowicz, Malgorzata; Aelion, Jacob; Greenwald, Maria; Diehl, Annette; Bhattacharya, Indranil; Peeva, Elena; Menon, Sandeep; Gourley, Ian 分享 收藏
分享 收藏
FILGOTINIB (GLPG0634), AN ORAL JAK1 SELECTIVE INHIBITOR IS EFFECTIVE AS MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM A 24-WEEK PHASE 2B DOSE RANGING STUDY Kavanaugh, A.; Ponce, L.; Cseuz, R.; Reshetko, O.; Stanislavchuk, M.; Greenwald, M.; Van der Aa, A.; Vanhoutte, F.; Tasset, C.; Harrison, P. 分享 收藏
FILGOTINIB (GLPG0634), AN ORAL JAK1 SELECTIVE INHIBITOR IS EFFECTIVE IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM A 24-WEEK PHASE 2B DOSE RANGING STUDY Westhovens, R.; Alten, R.; Pavlova, D.; Sosa, F. E. Enriquez; Mazur, M.; Greenwald, M.; Van der Aa, A.; Vanhoutte, F.; Tasset, C.; Harrison, P. 分享 收藏
BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS van der Heijde, D.; Dougados, M.; Chen, Y. -C.; Greenwald, M.; Drescher, E.; Klar, R.; Xie, L.; de la Torre, I.; Rooney, T. P.; Witt, S.; Schlichting, D.; DeBono, S.; Emery, P. 分享 收藏
A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis Cohen, Stanley; Emery, Paul; Greenwald, Maria; Yin, Donghua; Becker, Jean-Claude; Melia, Lisa Ann; Li, Ruifeng; Gumbiner, Barry; Thomas, Dolca; Spencer-Green, George; Meng, Xu 分享 收藏
BARICITINIB, AN ORAL JANUS KINASE (JAK)1/JAK2 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CDMARD THERAPY: RESULTS OF THE PHASE 3 RA-BUILD STUDY Dougados, M.; van der Heijde, D.; Chen, Y. -C.; Greenwald, M.; Drescher, E.; Liu, J.; Beattie, S.; de la Torre, I.; Rooney, T.; Schlichting, D.; de Bono, S.; Emery, P. 分享 收藏
TWO-YEAR CLINICAL RESPONSE TO BRODALUMAB, AN ANTI-IL-17 RECEPTOR ANTIBODY, IN PATIENTS WITH PSORIATIC ARTHRITIS Mease, P.; Genovese, M. C.; Greenwald, M. W.; Ritchlin, C. T.; Beaulieu, A.; Deodhar, A.; Newmark, R.; Feng, J.; Erondu, N.; Nirula, A. 分享 收藏
分享 收藏
A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors Genovese, Mark C.; Greenwald, Maria; Cho, Chul-Soo; Berman, Alberto; Jin, Ling; Cameron, Gregory S.; Benichou, Olivier; Xie, Li; Braun, Daniel; Berclaz, Pierre-Yves; Banerjee, Subhashis 分享 收藏
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis Mease, Philip J.; Genovese, Mark C.; Greenwald, Maria W.; Ritchlin, Christopher T.; Beaulieu, Andre D.; Deodhar, Atul; Newmark, Richard; Feng, JingYuan; Erondu, Ngozi; Nirula, Ajay 分享 收藏
A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis 一项多中心，随机，对照试验，以评估罗非昔布在晚期老年骨关节炎患者中的安全性，耐受性和疗效 Truitt, KE; Sperling, RS; Ettinger, WH; Greenwald, M; DeTora, L; Zeng, Q; Bolognese, J; Ehrich, E 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏